Serial Number | 79268101 |
Word Mark | ZELDA |
Filing Date | Monday, July 29, 2019 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Wednesday, March 24, 2021 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Medical cannabis and derivatives thereof; preparations for medical purposes derived from cannabis; therapeutic agents (medical); therapeutic creams (medical); therapeutic drugs (medical); natural healthcare preparations (medicaments); natural oils (medicinal); natural pharmaceutical products; pharmaceutical products derived from natural sources; pharmaceutical preparations; pharmaceutical preparations for human use; medical preparations; pharmaceutical preparations for health care; pharmaceutical preparations for nasal use; pharmaceutical preparations for oral use; pharmaceutical preparations for topical use; pharmaceutical preparations and substances for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, terminal illnesses, epilepsy, arthritis, crohn's disease, insomnia, diabetes, eczema, psychiatric diseases and disorders including mood disorders, anxiety disorders, sleep disorders, cognitive disorders, alzheimer's, depression, autism and post-traumatic stress disorder; pain killers (pharmaceuticals); pharmaceutical preparations in the form of foams, gels, emulsions, elixirs, lotions, ointments, tinctures, creams, liquids, oils, lozenges, tablets, capsules, sprays and skin patches; analgesic preparations; antibacterial preparations; medical products; medicinal plants and herbs; medicinal oils; herbal preparations for medical purposes; plant extracts for medical use; plant extracts for pharmaceutical use; preparations for medical purposes |
Goods and Services | Clinical trials; project management and planning of clinical trials; conducting clinical trials; research relating to pharmaceuticals; research relating to medicinal use of marijuana and cannabis; research and development of medicinal marijuana and cannabis products; medical research; medical research (scientific research for medical purposes); scientific research; research relating to science; provision of medical research services |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, October 2, 2019 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, October 2, 2019 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | ZELIRA THERAPEUTICS LIMITED |
Party Type | 10 - Original Applicant |
Legal Entity Type | 83 - NOT AVAILABLE |
Address | AU |
Event Date | Event Description |
Sunday, April 10, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Thursday, March 24, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
Thursday, March 24, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Wednesday, March 24, 2021 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
Wednesday, March 24, 2021 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Saturday, March 20, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
Wednesday, March 3, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, March 3, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
Saturday, January 2, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
Saturday, October 3, 2020 | REFUSAL PROCESSED BY IB |
Monday, September 7, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Thursday, September 3, 2020 | REFUSAL PROCESSED BY MPU |
Wednesday, August 5, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Tuesday, August 4, 2020 | NON-FINAL ACTION WRITTEN |
Tuesday, August 4, 2020 | ASSIGNED TO EXAMINER |
Friday, May 22, 2020 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
Sunday, October 20, 2019 | ASSIGNED TO EXAMINER |
Tuesday, October 8, 2019 | APPLICATION FILING RECEIPT MAILED |
Wednesday, October 2, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Thursday, September 26, 2019 | SN ASSIGNED FOR SECT 66A APPL FROM IB |